← Leaderboards
Matthew Durstenfeld
University Of California, San Francisco
$780,284
Attributed
$1,549,861
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $794.2K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,549,861 · 2
By mechanism
R01$1,154,365 · 1
K23$395,496 · 1
Top collaborators
- Priscilla Y. Hsue2 shared
- Ahmed A Tawakol2 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Priscilla Y. Hsue$28,957,856
- Alka M Kanaya$23,487,726
- Neeta Thakur$8,279,095
- Yuanquan Song$4,555,185
- Stacey Kenfield$4,338,642
Others in their field
Other Rising Stars on “Immune Activation”
- Angee Greer · Ppd Development Lp$82,531,927
- Rhea Coler · Seattle Children'S Hospital$35,184,139
- Suma Babu · Massachusetts General Hospital$11,004,714
- Sabrina Paganoni · Massachusetts General Hospital$11,004,714
- Warwick Britton · University Of Sydney$10,964,476
- Anice Lowen · Emory University$10,193,979
Research focus
Immune ActivationResourcesCoronary Computed Tomography AngiographyHiv InfectionsMultidisciplinaryPet/Ct ScanCardiovascular Disorder RiskCohortEnrollmentGeneral PopulationMortalityAtherosclerosisMyocardial InfarctionPersonsCardiometabolismCardiovascular DiseasesAntiretroviral TherapyChronicCoronary PlaqueDiabetes MellitusFluorodeoxyglucose Positron Emission TomographyFutureInflammationRisk Factors
Grant awards (4)
Cholesterol and inflammation Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)$557,915
R01 · FY2025 · HL
Low Cardiorespiratory Fitness and Chronotropic Incompetence inHIV: Risk Factors, Cardiovascular Implications, and Exercise Training as Treatment$197,748
K23 · FY2025 · HL · contact PI
Cholesterol and inflammation Lowering via BEmpedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)$596,450
R01 · FY2024 · HL
Low Cardiorespiratory Fitness and Chronotropic Incompetence inHIV: Risk Factors, Cardiovascular Implications, and Exercise Training as Treatment$197,748
K23 · FY2024 · HL · contact PI